APA

Marshall J., McEachern K. A., Chuang W., Hutto E., Siegel C. S., Shayman J. A., Grabowski G. A., Scheule R. K., Copeland D. P. & Cheng S. H. (20100928). Improved management of lysosomal glucosylceramide levels in a mouse model of type 1 Gaucher disease using enzyme and substrate reduction therapy. : Journal of inherited metabolic disease.

Chicago

Marshall John, McEachern Kerry Anne, Chuang Wei-Lien, Hutto Elizabeth, Siegel Craig S, Shayman James A, Grabowski Greg A, Scheule Ronald K, Copeland Diane P and Cheng Seng H. 20100928. Improved management of lysosomal glucosylceramide levels in a mouse model of type 1 Gaucher disease using enzyme and substrate reduction therapy. : Journal of inherited metabolic disease.

Harvard

Marshall J., McEachern K. A., Chuang W., Hutto E., Siegel C. S., Shayman J. A., Grabowski G. A., Scheule R. K., Copeland D. P. and Cheng S. H. (20100928). Improved management of lysosomal glucosylceramide levels in a mouse model of type 1 Gaucher disease using enzyme and substrate reduction therapy. : Journal of inherited metabolic disease.

MLA

Marshall John, McEachern Kerry Anne, Chuang Wei-Lien, Hutto Elizabeth, Siegel Craig S, Shayman James A, Grabowski Greg A, Scheule Ronald K, Copeland Diane P and Cheng Seng H. Improved management of lysosomal glucosylceramide levels in a mouse model of type 1 Gaucher disease using enzyme and substrate reduction therapy. : Journal of inherited metabolic disease. 20100928.